John M. Storring

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

Michael Wang, Wojciech Jurczak, Mats Jerkeman et al. · New England Journal of Medicine · 2022 · 216 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Heterodimerization of Mineralocorticoid and Glucocorticoid Receptors at a Novel Negative Response Element of the 5-HT1A Receptor Gene

Xiao‐Ming Ou, John M. Storring, Neena Kushwaha et al. · Journal of Biological Chemistry · 2001 · 177 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +10

Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen

John M. Storring, Mark D. Minden, Susan Kao et al. · British Journal of Haematology · 2009 · 148 citations · Full text

Medicine, Oncology, Chemotherapy +12

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Mohamed Shanavas, Uday Popat, Laura C. Michaelis et al. · Biology of Blood and Marrow Transplantation · 2015 · 142 citations · Full text

Medicine, Hematology, Immunology +13

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

Rena Buckstein, Richard A. Wells, Nancy Zhu et al. · British Journal of Haematology · 2016 · 97 citations · Full text

Medicine, Biostatistics, Frailty +16